Mednet Logo
HomePsychiatry
Psychiatry

Psychiatry

Expert discussions on psychopharmacology, behavioral health interventions, and psychiatric care approaches.

Recent Discussions

When do you consider antipsychotic augmentation of antidepressants for PTSD?

1 Answers

Mednet Member
Mednet Member
Psychiatry · Yale School Of Medicine Pitt Lab

Traditionally, antipsychotic augmentation of antidepressants was reserved for patients with high levels of paranoia or frank psychosis. The VA Cooperative Study of Risperidone also found that antipsychotic augmentation could be helpful for PTSD-related insomnia. The recent brexpiprazole study (Davis...

How do you counsel patients with mild to moderate depression interested in using St. John's Wort?

5
4 Answers

Mednet Member
Mednet Member
Psychiatry · Kirk Kerkorian School of Medicine at UNLV

Although this is used in parts of Europe, there it is considered a pharmaceutical and has higher standards for dose and potency. Here, as it is a health food product, different batches may require different doses of the pill due to differences in potency. There is some data to suggest that the combi...

What strategies do you find most effective at managing opioid withdrawal in hospitalized patients who are not interested in MAT?

1
3 Answers

Mednet Member
Mednet Member
Psychiatry · Vanderbilt University School of Medicine

There was a time when the majority of patients did not want maintenance on an opioid agonist (methadone), and we did not have partial agonists (buprenorphine) available. This underlines how far we have come in the last 15 or so years. At that time, all we did was use the alpha2 noradrenergic agonist...

How do you approach the titration of Ambien (zolpidem) to treat catatonia?

2 Answers

Mednet Member
Mednet Member
Psychiatry · Thapar Renu K Office

I have no experience of using Ambien for catatonia, but have read an article from the NIH library, which shows a promising alternative when lorazepam does not work and ECT is not available readily. These are only case reports. Research is needed.

How do you discuss sexual and gender identity-related anxiety with teens when family dynamics are rigid or culturally conservative?

1
2 Answers

Mednet Member
Mednet Member
Psychiatry · NYU Langone Health

First and foremost is safety. Never put children or teens in danger by hostile family or neighbors. In other words, don’t out them or encourage them to out themselves if they don’t feel safe doing so. You never know how people around them might react. That means be careful with your documentation, t...

What is your threshold for writing disability letters for patients with personality disorders?

4
4 Answers

Mednet Member
Mednet Member
Psychiatry · Private Pratice

I don't believe it's appropriate to have a threshold. Patients with personality disorders are often stigmatized and assumed to be manipulative or malingering. The criteria for writing a disability letter should be "Is the patient's disorder such that they are unable to work?" Assessing their recent ...

For those who don't have access to addiction medicine, have you considered using naltrexone for the treatment of stimulant use disorder in your primary care clinic?

2 Answers

Mednet Member
Mednet Member
Primary Care · Oregon Health & Science University

I am an addiction medicine clinician, and this is my general approach for treatment of stimulant use disorder (which is almost entirely methamphetamine use in my location of Portland, Oregon). Most of my patients have co-use of opioids, so they are typically unable to get onto naltrexone, and I reco...

In what cases do you use baclofen for alcohol use disorder?

7
3 Answers

Mednet Member
Mednet Member
Psychiatry · Massachusetts General Hospital

As Dr. @Dr. First Last mentioned, it's generally not a first-line choice (at least in the US). It is much more popular in Europe, but efficacy usually comes at notably higher doses. In one case series from 144 patients treated with baclofen in a French clinic, the mean maximum dose was 211 mg daily ...

Is there a potential role for GLP-1 receptor agonists in the management of premenstrual dysphoric disorder?

1 Answers

Mednet Member
Mednet Member
Psychiatry · Oregon Health Sciences University

This is an interesting question! I don't think we have enough information yet to answer, but I wouldn't be surprised if we find some benefit for PMDD, premenstrual exacerbation of symptoms, and PMS. This might be related to the anti-inflammatory effects of GLP-1 drugs, improved management of diabete...

What is your approach to evaluating Tardive Dyskinesia in nonverbal patients?

4
1 Answers

Mednet Member
Mednet Member
Neurology · VUMC Neurology

Nonverbal patients can still be affected by TD, so if there is a significant functional impact, treatment can still be offered. If a patient is completely unable to communicate, it is difficult to assess for side effects or symptomatic improvement, so the risk-to-benefit analysis would be largely un...